Kiyoshi Migita

Omura, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 323 publications

Low body weight as a risk factor for serious azathioprine-related adverse events in patients with rheumatic diseases.

Low body weight as a risk factor for serious azathioprine-related adverse events in patients with rheumatic diseases.

Journal: Immunological medicine
Published: July 29, 2026

Augmented Anti-Bactericidal Permeability-Increasing Protein Antibody Levels in Rheumatoid Arthritis Patients Complicated by Usual Interstitial Pneumonia.

Augmented Anti-Bactericidal Permeability-Increasing Protein Antibody Levels in Rheumatoid Arthritis Patients Complicated by Usual Interstitial Pneumonia.

Journal: Journal of clinical medicine
Published: June 10, 2026

Leukocytoclastic vasculitis of the extremities secondary to pancreatic cancer and Escherichia coli abscess; An unusual case of distinct etiologies in the same patient.

Leukocytoclastic vasculitis of the extremities secondary to pancreatic cancer and Escherichia coli abscess; An unusual case of distinct etiologies in the same patient.

Journal: Fukushima journal of medical science
Published: February 18, 2026

Concurrent Thyroid Tumor in an Elderly Patient with Giant Cell Arteritis: A Case Report.

Concurrent Thyroid Tumor in an Elderly Patient with Giant Cell Arteritis: A Case Report.

Journal: The Tohoku journal of experimental medicine
Published: January 21, 2026

Questionnaire-based nationwide survey on the safety of azathioprine in Japanese patients with rheumatic diseases: a cross-sectional study.

Questionnaire-based nationwide survey on the safety of azathioprine in Japanese patients with rheumatic diseases: a cross-sectional study.

Journal: Immunological medicine
Published: January 02, 2026

A case of systemic sarcoidosis with pituitary adrenal insufficiency complicated by eosinophilic gastroenteritis.

A case of systemic sarcoidosis with pituitary adrenal insufficiency complicated by eosinophilic gastroenteritis.

Journal: Fukushima journal of medical science
Published: December 14, 2025

A phase II investigator-initiated, continuation trial of 5-aminolevulinic acid hydrochloride/sodium ferrous citrate (5-ALA-HCl/SFC) for patients with adult-onset Still's disease (AOSD) refractory to glucocorticoids.

A phase II investigator-initiated, continuation trial of 5-aminolevulinic acid hydrochloride/sodium ferrous citrate (5-ALA-HCl/SFC) for patients with adult-onset Still's disease (AOSD) refractory to glucocorticoids.

Journal: Drug discoveries & therapeutics
Published: December 10, 2025

Association of elevated serum active IL-18 levels with cytokine profiles and clinical features in adult-onset still's disease.

Association of elevated serum active IL-18 levels with cytokine profiles and clinical features in adult-onset still's disease.

Journal: Frontiers in immunology
Published: December 03, 2025

Cutaneous sarcoidosis following complete remission of diffuse large B-cell lymphoma: a case report and literature review.

Cutaneous sarcoidosis following complete remission of diffuse large B-cell lymphoma: a case report and literature review.

Journal: Immunological medicine
Published: October 29, 2025

Peripheral blood UBA1 variant burden predicts poor outcomes in VEXAS syndrome: a nationwide prospective study.

Peripheral blood UBA1 variant burden predicts poor outcomes in VEXAS syndrome: a nationwide prospective study.

Journal: Annals of the rheumatic diseases
Published: October 27, 2025

A Phase-II Investigator-Initiated Randomized, Double-Blind, Parallel-Group Clinical Trial of 5-Aminolevulinic Acid Hydrochloride/Sodium Ferrous Citrate (5-ALA-HCl/SFC) for Patients With Adult-Onset Still's Disease (AOSD) Refractory to Corticosteroids.

A Phase-II Investigator-Initiated Randomized, Double-Blind, Parallel-Group Clinical Trial of 5-Aminolevulinic Acid Hydrochloride/Sodium Ferrous Citrate (5-ALA-HCl/SFC) for Patients With Adult-Onset Still's Disease (AOSD) Refractory to Corticosteroids.

Journal: Cureus
Published: August 17, 2025

Anti-Porphyromonas gingivalis lipopolysaccharide antibody in rheumatoid arthritis patients with emphysema.

Anti-Porphyromonas gingivalis lipopolysaccharide antibody in rheumatoid arthritis patients with emphysema.

Journal: Frontiers in medicine
Published: June 26, 2025
Showing 1-12 of 323

Last Updated: 09/26/2026